RecruitingNot ApplicableNCT07727239

Temporal Interference Stimulation of Hypothalamus in Patients With Narcolepsy Type 1

Efficacy and Safety of Temporal Interference Stimulation of Hypothalamus in Patients With Narcolepsy Type 1: A Randomised, Double-blind, Sham-Controlled, Single-Centre Trial


Sponsor

Xijing Hospital

Enrollment

24 participants

Start Date

Aug 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Narcolepsy type 1 (NT1) is a chronic brain disorder caused by selective loss or dysfunction of orexin (hypocretin) neurons in the lateral hypothalamus, for which current pharmacological treatments offer limited efficacy. Temporal interference (TI) stimulation is a recently developed noninvasive neuromodulation technique that enables focal modulation of deep brain structures. In this randomized, double-blind study, we developed a theta-burst patterned TI protocol and evaluated its effects in patients with NT1.


Eligibility

Min Age: 12 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Active Temporal Interference Stimulation and a medical device called Sham Temporal Interference Stimulation for people with narcolepsy type 1. The study is currently recruiting participants at 1 location. People eligible for this study include aged 12 Years to 60 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEActive Temporal Interference Stimulation

For the active TI stimulation, the current was applied for 40 minutes per session.

DEVICESham Temporal Interference Stimulation

For the sham stimulation, a brief 30-second current was delivered at the beginning and at the end of each session, with no current applied in between.


Locations(1)

Xijing Hospital

Xi'an, Shaanxi, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07727239


Related Trials